Markus Hossbach

This inventor holds 1 USPTO granted patent. Top assignee: Axolabs Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markus Hossbach. Retrieved from https://idiyas.com/inventor/markus-hossbach-kyn8xiei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Markus Hossbach

Introduction

Markus Hossbach is an accomplished inventor known for his contributions to the field of medical science. He has developed innovative solutions aimed at addressing significant health challenges. His work primarily focuses on muscular dystrophy, a condition that affects many individuals worldwide.

Latest Patents

One of Markus Hossbach's notable patents is titled "Muscle Targeting Complexes and Formulations for Treating Facioscapulohumeral Muscular Dystrophy." This patent represents a significant advancement in the treatment options available for this specific type of muscular dystrophy. He holds a total of 1 patent in this area.

Career Highlights

Markus Hossbach is currently associated with Axolabs GmbH, a company that specializes in providing innovative solutions in the life sciences sector. His role at Axolabs has allowed him to further his research and development efforts in the field of muscular dystrophy.

Collaborations

Throughout his career, Markus has collaborated with several talented individuals, including Timothy Weeden and Nelson Hsia. These collaborations have contributed to the advancement of his research and the successful development of his patented solutions.

Conclusion

Markus Hossbach is a dedicated inventor whose work has the potential to make a significant impact on the treatment of muscular dystrophy. His innovative approaches and collaborations highlight the importance of teamwork in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…